NDC Package 15054-1040-5 Increlex

Mecasermin Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
15054-1040-5
Package Description:
1 VIAL, MULTI-DOSE in 1 CARTON / 4 mL in 1 VIAL, MULTI-DOSE
Product Code:
Proprietary Name:
Increlex
Non-Proprietary Name:
Mecasermin
Substance Name:
Mecasermin
11-Digit NDC Billing Format:
15054104005
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 604806 - mecasermin 10 MG/ML Injectable Solution
  • RxCUI: 615882 - Increlex 10 MG/ML Injectable Solution
  • RxCUI: 615882 - mecasermin 10 MG/ML Injectable Solution [Increlex]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ipsen Biopharmaceuticals, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA021839
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    01-03-2006
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 15054-1040-5?

    The NDC Packaged Code 15054-1040-5 is assigned to a package of 1 vial, multi-dose in 1 carton / 4 ml in 1 vial, multi-dose of Increlex, a human prescription drug labeled by Ipsen Biopharmaceuticals, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 15054-1040 included in the NDC Directory?

    Yes, Increlex with product code 15054-1040 is active and included in the NDC Directory. The product was first marketed by Ipsen Biopharmaceuticals, Inc. on January 03, 2006 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 15054-1040-5?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 15054-1040-5?

    The 11-digit format is 15054104005. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-115054-1040-55-4-215054-1040-05